SLU-PP-332 is a synthetic small organic molecule (not a peptide), developed in the laboratories of Kendall Nettles and Thomas Burris at Saint Louis University and first published in 2023. As a relatively new molecule, it currently appears in more than 10 publications in the PubMed database, with the number of academic papers continuously growing. It belongs to the group of synthetic nuclear receptor agonists, which are a subject of active pharmacological research.
In academic literature, SLU-PP-332 most often appears in the context of research on ERR nuclear receptors (estrogen-related receptors) – a specific area of in-vitro receptor pharmacology. Scientific teams study it in cell models focused on ligand binding to the receptor and signal transduction.
In the laboratory, it is used as a reference analytical standard – for HPLC calibration, mass spectrometry (LC-MS), and comparative binding experiments with nuclear receptors. Cerebrotech supplies it as a powdered substance in a glass vial with a Certificate of Analysis (COA), with an HPLC-verified purity of ≥ 98%. A mass spectrum for each batch is available upon request.
A compatible solvent for reconstitution – bacteriostatic water – is available separately in our catalog. The product is intended exclusively for laboratory in-vitro research, biochemical analysis, and academic purposes. It is not a medicine, dietary supplement, or cosmetic product. It is not intended for human or animal consumption, application to the body surface, ingestion, or inhalation. Sale is contingent upon age 18+ verification.
